MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.82 -0.15 (-1.04%)
As of: Sep 4, 2026 · 3:14 PM EDT

MeiraGTx Holdings (MGTX) Research & Development (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Research & Development came in at $476000.0 in Q4 2025, up 100.66% YoY from $237212.7 in Q4 2024, and up 52.08% on a QoQ basis from $313000.0 in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Research & Development (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Research & Development data on file, last reported at $476000.0 in Q4 2025.

  • Quarterly Research & Development rose 100.66% year-over-year to $476000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.8 million (down 79.64% YoY) and the FY2025 annual result came in at $4.8 million, down 79.64% from the prior year.
  • Research & Development improved to $476000.0 in Q4 2025, from $313000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $34.9 million in Q2 2024 to a low of -$71.7 million in Q4 2024.
  • A 5-year average of $14.2 million and a median of $20.8 million in 2021 frame the typical range for Research & Development.
  • Annual changes were most pronounced in 2021 — Research & Development surged 367.21% — and 2024, when it plunged 312.97%.
  • Tracing MGTX's Research & Development over 5 years: stood at $13.2 million in 2021, then jumped by 65.11% to $21.8 million in 2022, then jumped by 54.7% to $33.7 million in 2023, then sank by 312.97% to -$71.7 million in 2024, then surged by 100.66% to $476000.0 in 2025.
  • The last three Research & Development figures came in at $476000.0 (Q4 2025), $313000.0 (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 993.80 Mn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 1.63 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -486.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 651.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 394.92 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 612.28 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 413.13 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 97.90 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 210.03 Mn
10 MeiraGTx Holdings 1.27 Bn 1.12 Bn 315.67 Mn 57.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.83 Mn
Dec 31, 2025 30.81 Mn
Sep 30, 2025 32.53 Mn
Jun 30, 2025 33.50 Mn
Mar 31, 2025 32.78 Mn
Dec 31, 2024 23.99 Mn
Sep 30, 2024 26.24 Mn
Jun 30, 2024 34.93 Mn
Mar 31, 2024 34.32 Mn
Dec 31, 2023 33.67 Mn
Sep 30, 2023 27.86 Mn
Jun 30, 2023 19.94 Mn
Mar 31, 2023 22.32 Mn
Dec 31, 2022 21.77 Mn
Sep 30, 2022 16.86 Mn
Jun 30, 2022 24.00 Mn
Mar 31, 2022 23.10 Mn
Dec 31, 2021 13.18 Mn
Sep 30, 2021 21.61 Mn
Jun 30, 2021 15.19 Mn